Excipient Engineering
Excipient Engineering is a methodological framework within pharmaceutical formulation science that involves the systematic design and modification of inert carrier materials to optimize the aerosolization, stability, and pulmonary delivery performance of active drug particles in dry powder inhalers.
186
Publications
8.3K
Citations
731
Authors
233
Institutions
Publications per year
2017–2026
67
Parents
186
Angus H. Forster, John Hempenstall, Ian G. Tucker et al. · International Journal of Pharmaceutics · 2001 · 394 citations
Roger Vandecruys, Jef Peeters, Geert Verreck et al. · International Journal of Pharmaceutics · 2007 · 163 citations
1–5 of 186
731
3
h-index
3
h-index
3
h-index
3
h-index
3
h-index
1–5 of 731
233
Pfizer (United States)
New York, United States
6 h-index
13 publications
637 citations

Centre National de la Recherche Scientifique
Paris, France
5 h-index
24 publications
635 citations
Purdue University West Lafayette
West Lafayette, United States
5 h-index
17 publications
544 citations
National University of Singapore
Singapore, Singapore
5 h-index
11 publications
319 citations

GlaxoSmithKline (United Kingdom)
London, United Kingdom
5 h-index
13 publications
1.2K citations

University of Nottingham
Nottingham, United Kingdom
4 h-index
10 publications
350 citations

Aston University
Birmingham, United Kingdom
4 h-index
15 publications
424 citations
Merck & Co., Inc., Rahway, NJ, USA (United States)
Rahway, United States
4 h-index
9 publications
201 citations
1–8 of 233
46 publications · 2.6K citations
26
h-index
14 publications · 669 citations
13
h-index
EJPB · 10 publications · 418 citations
10
h-index
7 publications · 253 citations
7
h-index
6 publications · 270 citations
6
h-index
1–5